Declining China Dat...
Health Care: Drugs
Incyte Corp Ltd (INCY: NASDAQ)
$22.17 -0.15 | -0.67%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 224.06M | 273.16M | 417.91M | 449.82M |
| Receivables | 70.95M | 6.42M | 5.70M | 163.66M |
| Inventories | 278.00K | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 309.51M | 310.78M | 455.45M | 656.06M |
| Property, Plant & Equipment, Gross | 36.00M | 33.37M | 29.80M | 25.78M |
| Accumulated Depreciation & Depletion | 29.66M | 26.94M | 24.99M | 24.03M |
| Property, Plant & Equipment, Net | 6.35M | 6.43M | 4.80M | 1.75M |
| Intangibles | 6.08M | 8.22M | 10.43M | 13.88M |
| Other Non-Current Assets | 8.48M | 3.54M | 18.89M | 40.70M |
| Total Non-Current Assets | 20.90M | 18.18M | 34.13M | 56.34M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 330.42M | 328.96M | 489.58M | 712.39M |
| Accounts Payable | 13.96M | 14.94M | 10.77M | 20.96M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 136.07M | 135.61M | 113.57M | 132.83M |
| Long Term Debt | 331.08M | 316.15M | 293.43M | 443.14M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 38.23M | 104.27M | 171.22M | 238.81M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 369.30M | 420.42M | 464.65M | 681.95M |
| Total Liabilities | 505.38M | 556.04M | 578.22M | 814.77M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -174.96M | -227.08M | -88.64M | -102.38M |
| Common Par | 133.00K | 126.00K | 123.00K | 119.00K |
| Additional Paid In Capital | 1.48B | 1.38B | 1.33B | 1.29B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -1.65B | -1.61B | -1.42B | -1.39B |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 1.88M | 1.64M | 1.99M | 707.00K |
| Total Capitalization | 156.12M | 89.08M | 204.79M | 340.75M |
| Total Equity | -174.96M | -227.08M | -88.64M | -102.38M |
| Total Liabilities & Stock Equity | 330.42M | 328.96M | 489.58M | 712.39M |
| Total Common Shares Outstanding | 133.46M | 126.47M | 123.28M | 118.89M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 129.75M | 125.36M | 121.63M | 102.94M |
| Diluted Weighted Shares Outstanding | 129.75M | 125.36M | 121.63M | 102.94M |
| Number of Employees | 413 | 368 | 247 | 221 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with INCY
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserMy Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Biotech Stocks Loved and...
Latest INCY Headlines from TheStreet
- Incyte Corp Ltd (INCY): Today's Featured Health Care Laggard 04.29.13 | 05:04 pm
- Incyte Corp Ltd (INCY): Drugs' Featured Underachiever Of The Day 04.02.13 | 05:04 pm
- INCY, PCYC, EW And A, 4 Health Care Stocks Pushing The Sector Lower 03.19.13 | 01:03 pm
- Incyte Stock Gaps Down On Today's Open (INCY) 03.18.13 | 10:03 am
- Incyte Corp Ltd (INCY): Today's Featured Drugs Winner 03.13.13 | 05:03 pm
- 4 Stocks Spiking on Unusual Volume 01.14.13 | 03:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- 13 Biotech Stock Predictions for 2013 01.02.13 | 06:01 am
- The Long YM Bio Nightmare Has Ended -- Happily. 12.12.12 | 09:12 am
- Biotech Earnings Preview: Vertex, Dendreon, Incyte, Medivation, Onyx (Updated) 10.31.12 | 07:10 am
Press Releases for INCY
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Incyte Corporation Of Class Action Lawsuit And The May 6, 2013 Lead Plaintiff Deadline - PR Newswire 04.23.13 | 03:04 pm
- Pittsburgh Law Office Of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf Of Shareholders Of Tangoe (TNGO) And Announces Investigations Of Atlantic Power Corp. (AT), Bazaarvoice (BV), Boeing (BA), Caterpillar (CAT), Diodes (DIOD), Harvest Natural Resources (HNR), Hess Corp. (HES), Impax Laboratories ( IPXL), Incyte Corp. (INCY), ITT Educational Services (ESI), - PR Newswire 04.12.13 | 07:04 pm
- Lifshitz Law Firm Announces Investigation Of Diodes, Inc., Incyte Corporation, And VeriFone Systems, Inc. - PR Newswire 04.09.13 | 07:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Incyte Corporation To Contact The Firm - PR Newswire 03.29.13 | 09:03 pm
- Law Offices Of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Incyte Corporation - Business Wire 03.25.13 | 05:03 pm
- Incyte Shareholder Alert: Briscoe Law Firm And Powers Taylor, LLP Announce Investigation Of Possible Breaches Of Fiduciary Duty - Business Wire 03.14.13 | 10:03 am
- Law Offices Of Howard G. Smith Announces Class Action Lawsuit Against Incyte Corporation - Business Wire 03.13.13 | 06:03 pm
- Incyte To Present At Upcoming Investor Conferences - Business Wire 02.20.13 | 08:02 am
- Incyte Reports 2012 Fourth-Quarter And Full-Year Financial Results; Provides 2013 Financial Guidance; Updates Shareholders On Key Clinical Programs - Business Wire 02.14.13 | 07:02 am
- Incyte To Report Fourth Quarter/Year-End 2012 Financial Results On February 14 - Business Wire 01.24.13 | 08:01 am
Partner Headlines for INCY
- Jefferies Reiterates Buy Rating, $36 PT on Incyte Corporation Despite PML Case - Benzinga 03.18.13 | 01:03 pm
- UPDATE: JP Morgan Reiterates Incyte Corporation at Overweight Following PML Case - Benzinga 03.18.13 | 01:03 pm
- Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis - Benzinga 11.15.12 | 08:11 am
- Incyte Narrows Loss - Analyst Blog - Zacks 11.06.12 | 09:11 am
- Novartis' Jakavi Gains EU Approval - Analyst Blog - NASDAQ 08.28.12 | 10:08 pm
- Novartis' Jakavi Gains EU Approval - Analyst Blog - Zacks 08.28.12 | 06:08 pm
- Revenues Rise at Incyte - Analyst Blog - Zacks 08.06.12 | 09:08 am
- After Hours Most Active for Aug 2, 2012 : SD, KCG, NOK, BAC, ORCL, ITUB, JPM, FB, QQQ, AAPL, INCY, ONNN - NASDAQ 08.02.12 | 08:08 pm
- Biotechs In Motion As New Drug Pipeline Brims - Investor's Business Daily 07.27.12 | 04:07 pm
- Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers - Seeking Alpha 07.13.12 | 06:07 pm
